Shares of Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) have earned a consensus rating of "Buy" from the seven analysts that are presently covering the company, MarketBeat reports. Seven investment analysts have rated the stock with a buy rating. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $23.57.
A number of equities research analysts have issued reports on OMDA shares. Barclays started coverage on Omada Health in a research note on Tuesday. They issued an "overweight" rating and a $21.00 price objective for the company. Wall Street Zen upgraded Omada Health to a "hold" rating in a report on Monday, June 16th. Evercore ISI began coverage on shares of Omada Health in a research report on Tuesday. They issued an "outperform" rating and a $21.00 price target for the company. JPMorgan Chase & Co. started coverage on Omada Health in a research note on Tuesday. They set an "overweight" rating and a $19.00 price objective for the company. Finally, Needham & Company LLC started coverage on shares of Omada Health in a research note on Tuesday. They issued a "buy" rating and a $23.00 target price for the company.
View Our Latest Analysis on OMDA
Omada Health Stock Up 2.9%
Omada Health stock traded up $0.53 during mid-day trading on Tuesday, reaching $18.63. 344,526 shares of the company's stock traded hands, compared to its average volume of 1,585,299. Omada Health has a 12-month low of $14.14 and a 12-month high of $28.40.
About Omada Health
(
Get Free ReportOmada's mission is to bend the curve. Our hope is that, one day, tomorrow's epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.
See Also
Before you consider Omada Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omada Health wasn't on the list.
While Omada Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
